Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Feb 03, 2023 8:07am
230 Views
Post# 35264231

RE:RE:RE:Baxter vs Seto and Co..

RE:RE:RE:Baxter vs Seto and Co..

Of course "fronting money " is a sign of strength. They didn't have to. Suggests that they like what they see from this Open label Trial. ( think "exceeding expectations") Even better than tranche #2 !

secondly it's a convertible debenture suggesting they are thinking about starting the share acquisition process. 

They never had control of DIMI, just a finite DA for USofA   Now it is true perpetual ownership of an entity in the worlds largest market, at a slightly reduced percentage,  in return for not having to spend as much going forward to bring it to commercialization ( or if you prefer, package it for sale) 

But you keep mounting your FUD campaign around admittedly annoying but less critical issues, just to drive the short- term price down, and keep new buyers away, and I'll keep reminding you of the true underlying value and real endgame. 


MM 

 

<< Previous
Bullboard Posts
Next >>